LDK Solar Co., Ltd. (NYSE:LDK) announced that its Board of Directors approved a share buyback program that authorizes LDK Solar to repurchase up to US$110 million of its American Depository Shares (”ADSs”) in the open market or through privately negotiated transactions. The program does not obligate LDK Solar to acquire any particular amount of its ADSs and may be modified or suspended at any time at the sole discretion of LDK Solar.
LDK Solar Co., Ltd., together with its subsidiaries, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products; and development of power plant projects.
********************
Crown Equity Holdings Inc., (CRWE)
There are different online marketing ways which have given a successful chance to market one’s brand on the Internet. These ways are unique and restricted only to the Internet platform which is offering many benefits to businesses.
Online marketing service caters to a vital function, reaching a new breed of consumers that are responsible for reshaping the way the market (and those who engage it) respond to an intelligent, informed and user-centric client that possesses vision, know-how and the ability to impact your brand with the drop of an email or one viral comment in the right place.
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
Crown Equity has the creative resources to dramatically enhance your company’s corporate identity with its in-house advertising and name-branding services. This includes creating, designing, implementing logos, and other strategies which rapidly increase your company’s credibility and value. As many people know, brand strength is a good indicator of the strength of a company and its financial value.
Crown Equity Holdings Inc. announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.
In addition to publishing to the mentioned countries, Crown Equity Holdings Inc. has also established online publishing sites for over 660 various cities within those countries.
For more information, visit http://www.crownequityholdings.com
********************
MF Global Holdings Ltd. (NYSE:MF) will release its fiscal first quarter 2012 financial results on Thursday, July 28, 2011. A press release will be issued at approximately 6:30 a.m. ET and will be available on the investor relations section of MF Global’s website, at http://www.mfglobalinvestorrelations.com. MF Global will host a conference call to discuss the quarter’s results at 7:30 a.m. ET. The public is invited to listen to the call.
MF Global Holdings Ltd., together with its subsidiaries, operates as a brokerage firm offering customized solutions in global cash and derivatives markets. It provides execution and clearing services for products in the exchange-traded and over-the-counter derivative markets, as well as for products in the cash market.
********************
Power3 Medical Products, Inc (PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Feelings of anxiety, frustration, embarrassment at not being able to do every day things and often depression can have a huge effect on Parkinson’s patients. These psychological symptoms occur as a result of the physical symptoms and can have a very negative effect on a person. Depressive episodes are seen in an average of 50% of patients and these episodes often alternate with anxiety attacks so that the patient has the symptoms of a manic-depressive. Alternating emotional outbursts of depression and anxiety are common in around 80% of cases.
The NuroPro Blood Test is Power3 Medical’s diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system.
The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms. The NuroPro Test is currently in the development stages.
Power3 Medical has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com
********************
Suntech Power Holdings Co. Ltd. (NYSE:STP) announced that Just-Roof™, Suntech’s best-selling building integrated photovoltaic (BIPV) product, has been approved by CEIAB in France and qualifies for the highest solar feed-in tariff for end customers.
Suntech Power Holdings Co., Ltd., a solar energy company, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products.
********************************************************************
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
